Benzinga's Top #PreMarket Losers
February 09, 2015 at 08:14 AM EST
Regulus Therapeutics Inc.(NASDAQ: RGLS) shares dropped 12.57% to $14.74 in pre-market trading after the company reported top-line ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.